FDA-Drug2017-01-11Class II
ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
Wells Pharmacy Network LLC
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide
Affected count
157 vials
Manufactured in
1210 SW 33rd Ave, N/A, Ocala, FL, United States
Products
ULTRA-TEST (CYP 80%/PROP 20%) Injectable, 250 mg/mL 10 mL vial, Compounded by Wells Pharmacy, Ocala, FL
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0328-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief